Fazio, Sergio <br/><br/>
Inhibition of apolipoprotein(a) synthesis by farnesoid X receptor and fibroblast growth factor 15/19: a step toward selective lipoprotein(a) therapeutics.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  May 2012 
 - 1060-2 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, N.I.H., Extramural; Comment 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.112.245571  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apolipoproteins A--genetics<br/>Atherosclerosis--genetics<br/>Female<br/>Fibroblast Growth Factors--metabolism<br/>Gene Expression Regulation<br/>Humans<br/>RNA, Messenger--genetics